Securities and Exchange Commission September 7, 2012 – Federal Register Recent Federal Regulation Documents

eHydrogen Solutions, Inc., and ChromoCure, Inc.; Order of Suspension of Trading
Document Number: 2012-22168
Type: Notice
Date: 2012-09-07
Agency: Securities and Exchange Commission, Agencies and Commissions
Notice of Applications for Deregistration Under Section 8(f) of the Investment Company Act of 1940
Document Number: 2012-22057
Type: Notice
Date: 2012-09-07
Agency: Securities and Exchange Commission, Agencies and Commissions
Applicant seeks an order declaring that it has ceased to be an investment company. On March 28, 2012, applicant made a liquidating distribution to its shareholders based on net asset value. Expenses of approximately $922 incurred in connection with the liquidation were paid by applicant. Filing Date: The application was filed on August 15, 2012. Applicant's Address: c/o The Dreyfus Corporation, 200 Park Ave., New York, NY 10166. Morgan Stanley Special Growth Fund
Order Making Fiscal Year 2013 Annual Adjustments to Registration Fee Rates
Document Number: 2012-22022
Type: Notice
Date: 2012-09-07
Agency: Securities and Exchange Commission, Agencies and Commissions
Cash Account Trust, et al.; Notice of Application
Document Number: 2012-22017
Type: Notice
Date: 2012-09-07
Agency: Securities and Exchange Commission, Agencies and Commissions
Summary of Application: Applicants request an order to permit the Money Market Portfolios (as defined below) to engage in principal transactions in certain taxable money market instruments including repurchase agreements with DBSI.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.